Change Is in the Air for Pharmaceutical Mergers – New York Times


Reuters Blogs
Change Is in the Air for Pharmaceutical Mergers
New York Times
The decision to sell its generics business to Teva Pharmaceutical for $40.5 billion when drug stocks were peaking in July 2015, and a subsequent attempt to sell the rest of the business to Pfizer in November, indicated that Brent Saunders, the chief of
Why Allergan plc (AGN), Krispy Kreme Doughnuts (KKD) and Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Are 3 Investorplace.com

all 132 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd